New investigational antibiotic effective against drug-resistant bacteria in phase 2 trial
Friday, October 26, 2018 - 09:30
in Health & Medicine
Results from a phase 2 randomised trial suggest that a new investigational antibiotic is as effective as the current standard-of-care antibiotic for the treatment of complicated urinary tract infections (UTIs) caused by several multidrug resistant Gram-negative bacteria.